Edgar Snyder & Associates®
A Law Firm Representing Injured People
1-866-943-3427
Call Us Toll Free 24/7
Published on Jun 22, 2011 by Edgar Snyder

Popular Smoking Cessation Drug Chantix Linked to Heart Attacks

Chantix linked to heart attack

The Food and Drug Administration (FDA) warns that the popular smoking cessation drug Chantix may increase patients' risk of chest pain and heart attack.

Chantix was approved in May 2006 and has been used by millions of Americans to help them stop smoking. Sales have declined, however, since 2008 – when the prescription medication was linked to risk of suicidal thoughts and depression. The drug's current label warns users about these side effects.

A new study of 700 patients showed that those taking Chantix experienced more heart problems – including heart attack and chest pain – than those taking a placebo drug. The FDA will add new warnings about the risk of heart problems to the drug's label. Patients will also receive new medication guides outlining those risks.

The drug's manufacturer, Pfizer, will be required to analyze a larger group of studies to determine how much Chantix patients are at risk. Another smoking cessation drug, Zyban, carries the same warning about heart-related side effects.

For more information about Chantix, visit EdgarSnyder.com.

"Stop-Smoking Pill Chantix May Cause Heart Attack, FDA Warns." CBSNews. June 17, 2011.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries

Recent News

Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Tweet